LLL

LENZ Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪419.52 M‬USD
−15.34USD
‪−124.65 M‬USD
‪17.84 M‬
Beta (1Y)
−0.10

About LENZ Therapeutics, Inc.

CEO
Evert B. Schimmelpennink
Headquarters
Del Mar
Employees (FY)
6
Founded
2013
FIGI
BBG00XDH4NZ2
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Del Mar, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LENZ is 15.96 USD — it has decreased by 2.86% in the past 24 hours. Watch LENZ Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LENZ Therapeutics, Inc. stocks are traded under the ticker LENZ.
LENZ Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
LENZ stock is 3.86% volatile and has beta coefficient of −0.10. Track LENZ Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is LENZ Therapeutics, Inc. there?
LENZ earnings for the last quarter are −2.57 USD per share, whereas the estimation was −0.91 USD resulting in a −182.94% surprise. The estimated earnings for the next quarter are −0.82 USD per share. See more details about LENZ Therapeutics, Inc. earnings.
LENZ Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.
Yes, you can track LENZ Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LENZ stock has risen by 1.08% compared to the previous week, the month change is a 20.99% fall, over the last year LENZ Therapeutics, Inc. has showed a 28.97% decrease.
LENZ net income for the last quarter is ‪−22.92 M‬ USD, while the quarter before that showed ‪−22.49 M‬ USD of net income which accounts for −1.93% change. Track more LENZ Therapeutics, Inc. financial stats to get the full picture.
Today LENZ Therapeutics, Inc. has the market capitalization of ‪419.52 M‬, it has decreased by 0.24% over the last week.
Like other stocks, LENZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LENZ Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
LENZ reached its all-time high on Jun 30, 2021 with the price of 238.00 USD, and its all-time low was 11.13 USD and was reached on Jan 6, 2023. View more price dynamics on LENZ chart.
See other stocks reaching their highest and lowest prices.
As of May 8, 2024, the company has 6.00 employees. See our rating of the largest employees — is LENZ Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LENZ Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LENZ Therapeutics, Inc. stock shows the sell signal. See more of LENZ Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LENZ Therapeutics, Inc. future price: according to them, LENZ price has a max estimate of 36.00 USD and a min estimate of 32.00 USD. Watch LENZ chart and read a more detailed LENZ Therapeutics, Inc. stock forecast: see what analysts think of LENZ Therapeutics, Inc. and suggest that you do with its stocks.